Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC Funds in Spain

Last updated: Apr 2024 A list of 50 VC funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.

Top 50 Life Science VC Funds in Spain

Investor	Life Science Spain investments
Capital Cell	7
Centre for the Development of Industrial Technology (CDTI)	6
Asabys Partners	4
Bullnet Capital	4
ENISA	4
Inveready	3
Invivo Capital Partners	3
Ysios Capital	2
Monte Carlo Capital	2
Alta Life Sciences	2
Speedinvest	2
Nara Capital	2
Amadeus Capital Partners	2
BoxOne Ventures	2
Caixa Capital Risc	2
Josep Carreras Leukaemia Research Institute	2
Charme Capital Partners	2
Demium Capital	2
Talis Capital	2
Xesgalicia	2
Amino Collective	2
ProVeg International	1
Clave Capital	1
Stemar Capital	1
Catalan Institution for Research and Advanced Studies	1
GENESIS Biomed	1
Global health sciences venture fund	1
BAGi	1
Clave Mayor	1
CDTI	1
Veg Capital	1
mVenturesBCN	1
Grow Venture Partners	1
New Enterprise Associates	1
Inveniam	1
Alantra	1
Grupo Ferrer Internacional	1
Alma Mundi Ventures	1
Good Seed Ventures	1
UCB Ventures	1
Sofinnova Partners	1
Addition	1
Innova-Tech Consulting	1
Green Generation Fund	1
Kurma Partners	1
Nina Capital	1
Fides Capital	1
Banc Sabadell and the Institut Català de Finances (ICF)	1
Novartis Venture Fund	1
Pontifax	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Funding Round, Seed
Spain, United States, United Kingdom

Portfolio highlights

Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

Ailin — Ailin offers digital health monitoring solutions with home self-sampling kits analyzed by Clínica Universidad de Navarra.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
KUMUX — Next generation smart-light devices

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Series B
Spain, Belgium, Germany

Portfolio highlights

Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Investment focus

Software, Information Technology, Enterprise Software
Funding Round, Series A, Seed
Spain, United States, Mexico

Portfolio highlights

Quside — Our QRNGs let innovators build advanced solutions for cybersecurity and computation.
wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
Deep Detection — Multispectral x-ray camera for food & beverage inspection

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

Imageryst — Imageryst is a cutting-edge SaaS platform that uses artificial intelligence and remote sensing to automatically extract exact, worldwide geolocated data from satellite imagery.
Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.
Muse Scene Lab — Perform with a virtual orchestra or band with Muse Scene Lab Suite and experiment: rehearsal enveloping, concert immersive experience, instrument selection, conductor & singer experience, all with classical, jazz, and popular repertoire.

We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.

Investment focus

Software, Biotechnology, Information Technology
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

MedUX — MedUX is the leading Customer Experience and Network monitoring solution for telecommunication services, governments, and OTT providers by using AI Powered Real-Time Applied Analytics
Scaleup Finance — Improve your financial management
All Structured Notes — All Structured Notes is the fintech specialized in the democratization of structured notes.

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Biotechnology, Health Care, Life Science
Seed, Funding Round, Series A
Spain, France, Belgium

Portfolio highlights

EsoBiotec — EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.
Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Investment focus

Medical Device, Artificial Intelligence, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
Rollstack — Rollstack is a tool that helps you create stunning and high-quality charts in minutes, embed data, and automate the creation of data-driven decks and docs - all within your favorite tools (Google Suite, Notion, Powerpoint)
Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Lapse — The new social camera for friends, not followers
Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
Necture — Ubiq enables mobility sharing operators to become profitable. Through demand prediction, demand fullfillment, predictive charging, dynamic pricing and policy compliance we provide tools for operational excellence.

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

Investment focus

Health Care, Medical Device, Health Diagnostics
Seed
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

Sitehop — Sitehop is a technology company creating innovative solutions for cyber-security and networking. Sitehop utilizes its custom FPGA solutions to optimize and accelerate cloud/telco networks.
Secondmind — Helping automotive engineers design better cars, faster.
Photonic — We are building a new world through scalable, fault-tolerant quantum technologies.

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Investment focus

Biotechnology, Health Care, Software
Seed, Pre-Seed, Series A
Canada, United States, Spain

Portfolio highlights

BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
HumanFirst — The complete productivity suite to transform natural language into business insights and AI training data
Pathway Medical — Pathway is an accurate and efficient point-of-care reference tool that gives you rapid access to evidence-based guideline summaries, interactive algorithms, key findings from landmark trials, clinical calculators, and more. Available anytime, anywhere.

Caixa Capital Risc (CCR) is the VC arm of CriteriaCaixa which invests in innovative companies in their start-up and growth stages. The company has three specialised teams in the areas of Information Technology, Life Sciences, and Industrial technologies. Caixa Capital Risc currently manages more than €300m through 11 specialised vehicles.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

inari — INARI provides blockchain, machine learning and artificial intelligence technologies for the Insurance industry
AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Mobile Media Content - TICKETING3D — Mobile Media Content, a Barcelona, Spain-based provider of virtual visualization technologies, raised €400k in seed funding.Founded in May 2012 by Michele Marino, CEO and Francis Casado, Head of Business Development, Mobile Media Content provides TICKETING3D, a SaaS 3D seating chart of a venue, which allows the final user to check the view fromhis seat before purchasing a ticket. It also Tranfer3D, which lets any club or sports organization to move supporters or fans from one location to another, and Match3D, a 2nd screening tool that allows following matches in real time.The company currently employs 20 people

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic

Investment focus

Software, Health Care, Information Technology
Pre-Seed, Seed, Series A
Spain, Portugal, Poland

Portfolio highlights

Coolx — Coolx has a mission to bring technology to the service of forests. Through satellite technology and AI we help environmental consultancies, engineers and forestry managers to optimize the analysis, management and forest conservation.
Tribboo — Project management platform for construction SMEs
Nuwe — Nuwe is a startup disrupting how tech professionals get hired and improve their skills, while at the same time it changes the way companies do people management and recruitment. To achieve that,we have developed a gamified platform which allows users to take challenges, participate in projects and contribute to Nuwe’s community sharing knowledgeand helping other users out. All of this contributes to their path to getting a job and their professional self-development.Companies can ask for personalized challenges, getting access to a database of validated users. For companies, wanting to participate in Nuwe’s selection processes not only get a database of validated users, but they generate a huge impact within tech communities which helps them gain a better reputation and have access to more qualified talent in the future. Moreover, companies can also ask for internal employee analytics which will help them optimize their overall performance.

We back founders who see the future differently.

Investment focus

Software, Information Technology, E-Commerce
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Acin — The Acin data Network and Diagnostics digitize and assure operational risk controls in a connected data Network across the industry.
Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Biomia — Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs in pain, addiction, and depression.
Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.

ProVeg International is an international non-governmental organisation that works in the field of food system change. ProVeg International works in four continents with eight offices.

Investment focus

Food and Beverage, Food Processing, Nutrition
Seed, Pre-Seed, Series A
China, Spain, France

Portfolio highlights

Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
ØZERS NUTRITION — ØZERS is a French foodtech that designs highly functional sports nutrition using only healthy and vegan ingredients. The company is lead by a professional boxer and engineer, working together with biotech engineers and doctors.Our products are made out of plant-based ingredients like plant proteins, microalgaes, vitamins and minerals.
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence

Clave Capital is an independent asset management company that specializes in investment strategy.

Investment focus

Biotechnology, Health Diagnostics, Health Care
Seed, Funding Round
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Nanological — Nanological is a public research organization, that focuses on pathogen identification devices. Nanological is a team of biosensing experts including physicists, biologists, data scientists, finance and business development experts, and clinical validation specialists.
ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

stemar capital private equity philippe costeletos

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

ICREA is a foundation supported by the Catalan Government for the advancement of research.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Life sciences R&D, consulting and investment

Investment focus

Medical, Health Care, Pharmaceutical
Seed, Pre-Seed
Spain

Portfolio highlights

Thytech — Thytech is a health tech company.
Telara Pharma — Telara Pharma designs a drug capable in the treatment and prevention of acute kidney injury.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series C, Series B
United States, Canada, Spain

Portfolio highlights

ARTMS — Expand your reach and astronomically increase your cyclotron production of large volumes of critical isotopes that are essential to the future of patient care.
EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.

BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.

Investment focus

Internet, Health Care, Information Technology
Seed, Angel, Funding Round
Spain, Norway, Switzerland

Portfolio highlights

Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
The Smart Lollipop — The Smart Lollipop is the non-invasive medical device in the shape of a lollipop for the diagnostic and disease monitoring through a saliva sample. The sweetest lab is The Smart Lollipop.

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Software, Biotechnology, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

Jeff — Jeff is a company created in 2015 by Eloi Gómez, Adrián Lorenzo and Rubén Muñoz, three Spanish entrepreneurs. It started as a home laundry and dry-cleaning app, but is currently in an expansion process in which, in addition to laundry service, different day-to-day services are added such as hairdressing and beauty, fitness and massages, becomingthe first international omnichannel ecosystem of day-to-day services. It is available to anyone who wants to invest or undertake the necessary solutions to launch their own business under the business lines of the Jeff brand.
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
Predictheon — Predictive monitoring for clinicians. Real-time predictions about patient health status to personalize medical care, adjust and individualize therapy, and improve safety.

Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Debt Financing
Spain, United States, Mexico

Portfolio highlights

Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.

Investment focus

Food and Beverage, Biotechnology, Restaurants
Seed, Equity Crowdfunding, Pre-Seed
United Kingdom, Sweden, Brazil

Portfolio highlights

Super Vegan — Loja de chocolates veganos
SpiceBox — SpiceBox is your local, award-winning curry house in Walthamstow & Leytonstone. We serve fresh and flavourful Indian food that happens to be vegan. Carefully crafted, freshly made with bags of character and style. We're open for dinner Tues-Sun and brunch on the weekends. We also offer zero-emissions delivery.
THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.

You can find here all the institution, its legal framework, as well as the economic and administrative reports and data

Investment focus

Biopharma, Health Care, Life Science
Seed
Spain

Portfolio highlights

RheoDx — We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as bloodcoagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Investment focus

Biotechnology, Robotics, Biopharma
Pre-Seed, Funding Round
Spain

Portfolio highlights

Floatech — Floatech develops high-performance silicon anodes for advanced technology industries. Their proprietary process yields high-performance qualities in LIBs while combining manufacturing sustainability and scalability.
teknoCEA — TeknoCEA is a company expert in power electronics and R+D+i
Virmedex — Experience healthcare training with our video games, VR, and AI technology. Practice, repeat, and, most importantly... have fun!

Foundational partners to ambitious founders at every stage of company-building.

Investment focus

Software, Health Care, Biotechnology
Series B, Series A, Series C
United States, India, China

Portfolio highlights

Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
Foundry — Elastic cloud infrastructure built for machine learning.
Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.

Being at the forefront of technology takes courage, perseverance, knowledge and experts guiding you to lead the change. Our services Financial & transaction advisory Details Consulting Details Public Funding Details Inveniam numbers since 2020 180 Clients 64 Active Projects 30 Energy andTechnical Audits 42 Strategic and Innovation Consulting Projects 31% Success Rate in Horizon Europe

Investment focus

Biopharma, Health Care, Life Science
Seed, Funding Round
Spain

Portfolio highlights

AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.

ALANTRA is a PROJECT, a firm being built by all its partners and professionals, a collective aspiration which aims to become an enduring institution for the generations to come. It is a GLOBAL FIRM, being founded by the partners of the 19 countries we are present in.It is an open firm, articulated around the principles of ENTREPRENEURSHIP,PARTNERSHIP, INNOVATION and FLEXIBILITY.Their segment is the MID-MARKET, a space for growth, for new ambitions, for creative and innovative spirits. We grow with our clients, we share their mindset and we build very long-term relationships with them.

Investment focus

Financial Services, Manufacturing, Information Technology
Private Equity, Debt Financing, Series B
Spain, France, Sweden

Portfolio highlights

enmacc — The enmacc OTC platform is a energy trading platform for the future of the global energy markets. We are building a next-generation trading platform, powered digital RFQ technology, that will help you to trade smarter, faster and better.
SunRoof — Roof of the future
Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.

Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.

Investment focus

Biotechnology, Wellness, Biopharma
Series A, Funding Round
Spain

Portfolio highlights

Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.

We back bold and purpose-driven founders.

Investment focus

Software, Insurance, InsurTech
Series A, Seed, Funding Round
Spain, United States, United Kingdom

Portfolio highlights

Life5 — Really easy life insurance. By humans, for humans.
Raincoat — Get the policy that offers you cash after the hurricane, without deductibles or having to make claims!
REVER — REVER is born to disrupt how eCommerce returns work by making them easier and faster for everyone.

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Pre-Seed
Germany, Israel, United States

Portfolio highlights

Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.

UCB Ventures is a €150 million strategic corporate venture fund

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, Belgium, Spain

Portfolio highlights

Splice Bio — We are working with our proprietary platform to address key limitations of current gene therapy approaches to treat patients in need.
Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
Code Biotherapeutics — Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.

Investment focus

Software, Financial Services, FinTech
Series A, Series B, Series C
United States, Brazil, Canada

Portfolio highlights

OneChronos — OneChronos ATS: The Smart Market for Institutional Investors
SuperOps.ai — SuperOps.ai is an early stage startup in the MSP space.
Daedalus — Daedalus develops reconfigurable production capacity that can be retooled instantly. Its robotics and AI technologies enable agile manufacturing for any process, volume, and part complexity.

Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.

Investment focus

Solar, Energy, Medical
Series A, Seed, Series B
Canada, Spain

Portfolio highlights

SiXtron Advanced Materials — I found a great domain name for sale on Dan.com. Check it out!
Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.

The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Pre-Seed, Series A
Germany, United States, Spain

Portfolio highlights

Reverion — Reverion offers electrical efficiencies for both power generation and energy storage. Reverion was foun ded in 2022 and was headquartered in Bayern, Germany.
smatch — Smatch takes care of stock management and helps retailers to better buy merchandise.
Change Foods — We (re)create real dairy foods that delight the taste buds, nourish people and sustain the planet, by using the magic of microbes instead of animals.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Series B, Seed
France, Spain, Switzerland

Portfolio highlights

Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)

Investment focus

Telecommunications, Software, Automotive
Seed, Pre-Seed, Series A
Spain

Portfolio highlights

Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Energy Solar Tech — Energy Solar Tech is a solar energy technology company.

Banc Sabadell and the Institut Català de Finances (ICF)

Investment focus

Wellness, Health Care, Medical Device
Pre-Seed, Series A, Debt Financing
Spain

Portfolio highlights

Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
Adan Medical Innovation — Adan Medical is a digital health company that develops integrated solutions for the management of anaphylaxis. Their mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine.The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays twodifferent products in its pipeline: AnAPPhylaxis, a smart case for epinephrine auto-injectors connected to a mobile App, and WE SAVE, a smart box of epinephrine auto-injectors for public spaces.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate